131 related articles for article (PubMed ID: 24850797)
1. Endothelial transcriptome in response to pharmacological methyltransferase inhibition.
Okabe J; Fernandez AZ; Ziemann M; Keating ST; Balcerczyk A; El-Osta A
ChemMedChem; 2014 Aug; 9(8):1755-62. PubMed ID: 24850797
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of arginine and lysine methyltransferases induces nuclear abnormalities and suppresses angiogenesis in human endothelial cells.
Balcerczyk A; Rybaczek D; Wojtala M; Pirola L; Okabe J; El-Osta A
Biochem Pharmacol; 2016 Dec; 121():18-32. PubMed ID: 27659811
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of carboxy analogues of arginine methyltransferase inhibitor 1 (AMI-1).
Castellano S; Milite C; Ragno R; Simeoni S; Mai A; Limongelli V; Novellino E; Bauer I; Brosch G; Spannhoff A; Cheng D; Bedford MT; Sbardella G
ChemMedChem; 2010 Mar; 5(3):398-414. PubMed ID: 20091730
[TBL] [Abstract][Full Text] [Related]
4. An inhibitor of protein arginine methyltransferases, 7,7'-carbonylbis(azanediyl)bis(4-hydroxynaphthalene-2-sulfonic acid (AMI-1), is a potent scavenger of NADPH-oxidase-derived superoxide.
Chen F; Fulton DJ
Mol Pharmacol; 2010 Feb; 77(2):280-7. PubMed ID: 19903831
[TBL] [Abstract][Full Text] [Related]
5. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
6. Upregulated protein arginine methyltransferase 1 by IL-4 increases eotaxin-1 expression in airway epithelial cells and participates in antigen-induced pulmonary inflammation in rats.
Sun Q; Yang X; Zhong B; Jiao F; Li C; Li D; Lan X; Sun J; Lu S
J Immunol; 2012 Apr; 188(7):3506-12. PubMed ID: 22387551
[TBL] [Abstract][Full Text] [Related]
7. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.
Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y
J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651
[TBL] [Abstract][Full Text] [Related]
8. Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17.
Miao F; Li S; Chavez V; Lanting L; Natarajan R
Mol Endocrinol; 2006 Jul; 20(7):1562-73. PubMed ID: 16497732
[TBL] [Abstract][Full Text] [Related]
9. Histone methyltransferases in Aspergillus nidulans: evidence for a novel enzyme with a unique substrate specificity.
Trojer P; Dangl M; Bauer I; Graessle S; Loidl P; Brosch G
Biochemistry; 2004 Aug; 43(33):10834-43. PubMed ID: 15311944
[TBL] [Abstract][Full Text] [Related]
10. Novel symmetrical ureas as modulators of protein arginine methyl transferases.
Fontán N; García-Domínguez P; Álvarez R; de Lera ÁR
Bioorg Med Chem; 2013 Apr; 21(7):2056-67. PubMed ID: 23395110
[TBL] [Abstract][Full Text] [Related]
11. Deep sequencing reveals novel Set7 networks.
Keating ST; Ziemann M; Okabe J; Khan AW; Balcerczyk A; El-Osta A
Cell Mol Life Sci; 2014 Nov; 71(22):4471-86. PubMed ID: 24875254
[TBL] [Abstract][Full Text] [Related]
12. Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.
Zhang B; Zhang S; Zhu L; Chen X; Zhao Y; Chao L; Zhou J; Wang X; Zhang X; Ma N
Toxicol Appl Pharmacol; 2017 Dec; 336():1-7. PubMed ID: 28987382
[TBL] [Abstract][Full Text] [Related]
13. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M
ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory study of protein arginine methyltransferase 1 using a fluorescent approach.
Feng Y; Xie N; Wu J; Yang C; Zheng YG
Biochem Biophys Res Commun; 2009 Feb; 379(2):567-72. PubMed ID: 19121292
[TBL] [Abstract][Full Text] [Related]
15. [Advances in histone methyltransferases and histone demethylases].
Wang X; Zhu WG
Ai Zheng; 2008 Oct; 27(10):1018-25. PubMed ID: 18851779
[TBL] [Abstract][Full Text] [Related]
16. PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells.
Bajbouj K; Ramakrishnan RK; Saber-Ayad M; Omar HA; Saheb Sharif-Askari N; Shafarin J; Elmoselhi AB; Ihmaid A; AlHaj Ali S; Alalool A; Abdullah R; Hamid Q
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200178
[TBL] [Abstract][Full Text] [Related]
17. Protein Arginine Methyltransferase (PRMT) Inhibitors-AMI-1 and SAH Are Effective in Attenuating Rhabdomyosarcoma Growth and Proliferation in Cell Cultures.
Janisiak J; Kopytko P; Tkacz M; Rogińska D; Perużyńska M; Machaliński B; Pawlik A; Tarnowski M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360791
[TBL] [Abstract][Full Text] [Related]
18. An RNA-seq transcriptome analysis of histone modifiers and RNA silencing genes in soybean during floral initiation process.
Liew LC; Singh MB; Bhalla PL
PLoS One; 2013; 8(10):e77502. PubMed ID: 24147010
[TBL] [Abstract][Full Text] [Related]
19. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive.
Guccione E; Bassi C; Casadio F; Martinato F; Cesaroni M; Schuchlautz H; Lüscher B; Amati B
Nature; 2007 Oct; 449(7164):933-7. PubMed ID: 17898714
[TBL] [Abstract][Full Text] [Related]
20. Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases.
Dowden J; Hong W; Parry RV; Pike RA; Ward SG
Bioorg Med Chem Lett; 2010 Apr; 20(7):2103-5. PubMed ID: 20219369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
